IPR: ‘Developing countries need to be cautious’
The Indian Supreme Court’s verdict in the Novartis case over patent rights has opened up the debate on intellectual property rights (IPR) in India, and globally. Gateway House interviews Narendra Sabharwal, Chair, IPR Committee, FICCI, to discuss the role of IPR and public health concerns in emerging economies.